Ipsen’s Post

The publication of this year’s Sustainability Report fills me with huge pride for Merck Healthcare. Firstly, because of how much has been achieved since we established our three clear sustainability goals in 2020, in line with the UN Sustainable Development Goals (#SDGs). We have not only implemented environmentally progressive processes and projects across our Healthcare business, but also continue to dedicate ourselves to human progress, as an example, by strengthening our patient access strategy in low- and middle-income countries, ensuring that all patients across the globe can benefit from our medicines. Secondly, I am proud of the commitment that our teams show as we look to the future of our sustainability strategy. We continue to set ambitious targets that will impact society for good, notably our goal of eliminating schistosomiasis as a public health problem by 2030. Our success lies in the focus and capabilities of our teams as well as our collaboration with the many external partners and organizations that we are proud to work with, enabling us to embed sustainable change throughout Merck and beyond.   Read the full report here: https://lnkd.in/epm7Fsfh Merck Group #Sustainability #TeamMerck

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives. #ESG #climatechange #sustainability

Miriam Wrobel, Global Leader of ESG and Sustainability, will be leading the panel "Driving Change: ESG Implementation Across Global Supply Networks" at the ESG Life Sciences conference, alongside John Iskander from Meissner. They’ll discuss how companies are tackling ESG challenges across global supply chains. If you’re attending, don’t miss the chance to connect with Miriam and explore how FTI can support your ESG strategies! #ESG #Sustainability #LifeSciences #FTIConsulting #SupplyChain

Miriam Wrobel, Global Leader of ESG and Sustainability, will be leading the panel "Driving Change: ESG Implementation Across Global Supply Networks" at the ESG Life Sciences conference, alongside John Iskander from Meissner. They’ll discuss how companies are tackling ESG challenges across global supply chains. If you’re attending, don’t miss the chance to connect with Miriam and explore how FTI can support your ESG strategies! #ESG #Sustainability #LifeSciences #FTIConsulting #SupplyChain

Miriam Wrobel, Global Leader of ESG and Sustainability, will be leading the panel "Driving Change: ESG Implementation Across Global Supply Networks" at the ESG Life Sciences conference, alongside John Iskander from Meissner. They’ll discuss how companies are tackling ESG challenges across global supply chains. If you’re attending, don’t miss the chance to connect with Miriam and explore how FTI can support your ESG strategies! #ESG #Sustainability #LifeSciences #FTIConsulting #SupplyChain

Miriam Wrobel, Global Leader of ESG and Sustainability, will be leading the panel "Driving Change: ESG Implementation Across Global Supply Networks" at the ESG Life Sciences conference, alongside John Iskander from Meissner. They’ll discuss how companies are tackling ESG challenges across global supply chains. If you’re attending, don’t miss the chance to connect with Miriam and explore how FTI can support your ESG strategies! #ESG #Sustainability #LifeSciences #FTIConsulting #SupplyChain

Miriam Wrobel, Global Leader of ESG and Sustainability, will be leading the panel "Driving Change: ESG Implementation Across Global Supply Networks" at the ESG Life Sciences conference, alongside John Iskander from Meissner. They’ll discuss how companies are tackling ESG challenges across global supply chains. If you’re attending, don’t miss the chance to connect with Miriam and explore how FTI can support your ESG strategies! #ESG #Sustainability #LifeSciences #FTIConsulting #SupplyChain

Pharmaceutical companies, like all industries, are now facing a myriad of regulatory (EU Taxonomy, CSRD, ESRS, REACH), environmental (energy efficiency, water usage, waste management), social (employee health & safety, community engagement), and governance (ethical conduct, transparency, accountability) requirements. The complexity of these reporting obligations can be daunting. However, ESGenius! - The Sustainability OS offers a powerful tool to simplify and streamline the sustainability journey. Join us today at CLEON Conferences & Communications to discover how technology can be your ally in meeting these challenges and achieving your sustainability goals! 🗨️ "Ενσωμάτωση των κριτηρίων ESG και κανονιστική συμμόρφωση με τη βοήθεια της τεχνολογίας. Μετατρέποντας τις προκλήσεις σε ευκαιρία στη φαρμακευτική βιομηχανία" 📍Divani Caravel Hotel 🗓️ July 2, 14.45-15.45 #Sustainability #Pharma #ESG #Technology #Compliance #SustainabilityJourney #Innovation

Since this year, Swiss-listed companies of a certain size have to publish a sustainability report and submit it to their shareholders for approval. Such transparency is obviously a good thing. It gives investors a better understanding of how companies are managing their environmental and social issues and, when transparency and policies in this area are not deemed to be sufficient, allows them to send a message to the board of directors. This is exactly what Fondation Ethos is doing today by explaining why it opposes Roche's sustainability report, the AGM of which will take place tomorrow in Basel. More information right here ⬇️ #ActiveOwnership #ProxyVoting https://lnkd.in/eyJqnXFb